Minerva Neurosciences, Inc. - Special Call Transcript
Greetings, and welcome to the KOL call on roluperidone, a novel mechanism to treat the negative symptoms of schizophrenia, hosted by Minerva Neuroscience. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Bill Boni, Vice President of Investor Relations and Corporate Communications at Minerva Neurosciences. Please go ahead.
Good morning, and welcome, everyone. On behalf of Minerva, thank you for attending this call, especially given the challenges we are all facing with the coronavirus. Today's speakers include Dr. Ofer Agid, Dr. Will Carpenter, Dr. John Kane and Dr. Stephen Marder.
The discussion will be moderated by Dr. Rémy Luthringer, Executive Chairman and CEO of Minerva. Also present from Minerva, is Dr. Michael Davidson, Chief Medical Officer.
Dr. Agid is Clinician Scientist and Psychiatrist in the Schizophrenia Program and Medical Head, Ambulatory Services and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |